The testing of archival biopsy specimens has found “near-universal expression” of DLL3 in SCLC tumors, leading researchers to explore the role of DLL3 in predicting which patients might benefit from ...

There is no evidence of ivermectin being effective in treating cancer, but the NCI is studying it as a potential treatment option.

The researchers conducted a retrospective analysis of costs associated with hospitalization of CLL patients with serious infections.

In this case-control study, researchers used Finnish registry data to assess the associations between induced abortion or miscarriage and breast cancer risk.

Investigators sought to determine when malnutrition appears in patients with GI cancer and how nutritional status affects quality of life and fatigue during treatment.

Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.

In this phase 3 study, researchers sought to determine whether the addition of palbociclib may overcome resistance to endocrine and HER2-directed therapies.

The purpose of this survey was to combine qualitative and quantitative insights to understand the current oncology landscape.

In this study, researchers used the SEER-21 database to calculate 1-year cause-specific survival rates in patients diagnosed with a first primary malignant cancer between January 1, 2020, and December ...

TEXT Treatment patterns and real-world survival outcomes varied by race/ethnicity, socioeconomic status, and practice setting in a cohort of women treated ...

Clinicians debunked common myths and misinformation regarding sunscreen necessity and safety that is gaining traction among young patients and online.

Conferences can be an excellent way to connect with fellow oncologists and stay informed on the latest research. These events are key to providing ...